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ABSTRACT
Fundamental Cause Theory suggests the replacement of
mechanisms that produce the persistent relationship between
socioeconomic status and health over time. Understanding how
this process operates is central to explaining the reproduction of
health inequality. We use data from the Onco-barometer survey
(2010) to test a set of hypotheses derived from FCT, Diﬀusion Of
Innovations theory and the intersection between these theories to
examine how socioeconomic inequality emerges and evolves
across the cycle of diﬀusion of six relevant preventive practices in
Spain: faecal occult blood tests, prostate-speciﬁc antigen tests,
Papanicolaou tests, mammograms, cholesterol readings and
blood-pressure checks. Because these preventive measures are
characterised by diﬀering rates of spontaneous knowledge and
use amongst the Spanish population, we assume that they are at
diﬀerent stages in the diﬀusion cycle. Results suggest that SES has
a dynamic inﬂuence according to the diﬀusion stage of each
preventive measure. We argue that the conjunction of these
theories oﬀers a dynamic ‘imagery’ that can help to explain the
generation and diminishment of inequalities. Moreover, this
integration has the potential to bring ‘social change’ back into the
study of health inequalities, which is essential to understanding
equitable (and inequitable) returns produced by preventive
innovations.
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Since the 1990s, sociological perspectives have been gaining ground in the study of health
inequalities. In this context, Link and Phelan (1995) reformulate the ‘social causation’
arguments from a sociological viewpoint, thereby developing Fundamental Cause
Theory (FCT). This theory revives the question of which social circumstances or factors
put people ‘at risk of risks’ and calls for consideration to be given to the social contexts
that determine speciﬁc risk factors. It also directs interest back to how the distribution
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of resources and knowledge across socioeconomic status (SES) groups can preserve health
inequalities, even in the light of dramatic changes in speciﬁc proximal risk factors. Health
inequalities are seen as being rooted in the pre-existing social stratiﬁcation, which pro-
duces a speciﬁc distribution of resources (knowledge, money, power, prestige and ben-
eﬁcial social connections) amongst social groups. The main argument is that these
resources shape whether individuals are aware of, have access to, can aﬀord and are sup-
ported in their eﬀorts to engage in health-enhancing behaviours. Consequently, when new
health-enhancing capabilities emerge, those with greater access to ﬂexible resources can
beneﬁt from them earlier and to a greater extent than can those with fewer ﬂexible
resources. For this reason, health inequalities are continually shaped (and re-shaped) as
we develop more control over disease and death (Phelan & Link, 2005). FCT assumes a
dynamic relationship between socioeconomic status and health-related events, given
that new axes of inequality in health emerge as the old axes persist or diminish in
importance.
The central role of ﬂexible resources linked to socioeconomic status (SES) has been
tested empirically by comparing situations in which they can be eﬀectively deployed to
other circumstances in which it is not possible to use them in a beneﬁcial manner, as is
the case when little or nothing is known about how to prevent disease and mortality
(Phelan, Link, Diez-Roux, Kawachi, & Levin, 2004; Rubin, Clouston, & Link, 2014). More-
over, empirical tests of FCT have also compared the evolution of health inequalities before
and after the introduction of new technological innovations or new health-enhancing
knowledge, to analyse how health inequality emerges, or whether the relationship
between SES and speciﬁc health outcomes is shaped (or re-shaped). For example, this
occurs with the emergence of life-extending treatments (e.g. HIV/AIDS medicines,
statins to reduce cholesterol, the human papilloma virus vaccine, eﬀective cancer screening
or selective serotonin reuptake inhibitors in the case of suicide) (Chang & Lauderdale,
2009; Clouston, Rubin, Colen, & Link, 2014; Link, Northridge, Phelan, & Ganz, 1998;
Polonijo & Carpiano, 2013; Rubin, Colen, & Link, 2010; Saldana-Ruiz, Clouston, Rubin,
Colen, & Link, 2013; Tehranifar et al., 2009). In similar vein, recent research in 20 Euro-
pean countries has shown faster mortality declines amongst high-SES groups relative to
low-SES groups for causes of death that are amenable to intervention, but not for non-
amenable causes (Mackenbach et al., 2017).
Despite the eﬀorts of these empirical studies, the speciﬁc underlying mechanisms that
drive the process of reproduction of inequalities over time remain poorly understood.
More speciﬁcally, the literature lacks any in-depth explanation of the time dimension of
FCT – the evolution of inequalities over time. FCT would thus beneﬁt from integration
with another theoretical framework that oﬀers a perspective that explains trends over
time regarding the equity impact of health technologies. Diﬀusion of innovation (DOI)
theory (Rogers, 1983) is well-suited to ﬁll in the less-elaborated time dimension of FCT.
Technological developments are key components of both theoretical frameworks. While
FCT focusses on their unequal use and impact on health inequality, DOI theory highlights
their adoption and diﬀusion over time. In particular, DOI theory predicts that technologi-
cal innovations spread through the population in a predictable pattern (Rogers, 1983).
Although this theory has been widely used in public health research (Greenhalgh et al.,
2005; Haider & Kreps, 2004), only recently have scholars begun to use DOI theory
models to explore the possible inﬂuence of changing patterns of health-related habits
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and the diﬀusion of preventive innovations on the magnitude of social inequalities
(Centola, 2011; Elstad, 2013; Glied & Lleras-Muney, 2008; Wang, Clouston, Rubin,
Colen, & Link, 2012).
The main objective of the current study is to elaborate on FCT by applying the theoretical
principles of DOI theory to preventive healthcare use. We argue that FCT should assign in-
depth consideration to the relevance of the diﬀusion contexts of preventive practices, in
accordance with its proposition concerning the dynamic association between SES and
health over time. More speciﬁcally, we test a set of hypotheses derived from FCT, DOI
theory and the intersections between these theories to examine how socioeconomic inequal-
ity emerges and evolves across the cycle of diﬀusion for six relevant preventive practices in
Spain: (1) faecal occult blood (FOB) tests; (2) prostate-speciﬁc antigen (PSA) tests, only for
men; (3) Papanicolaou tests (Pap smears) and (4) mammograms, only for women; (5)
cholesterol readings and (6) blood-pressure checks. Because these preventive practices are
characterised by diﬀering rates of spontaneous knowledge and use amongst the Spanish
population, we assume that they are at diﬀerent stages of the diﬀusion cycle.
Theoretical framework and hypotheses
Fundamental causality propositions
The main contribution of FCT has been the development of a theoretical framework that
reveals paths that link socioeconomic status (SES) to health and that can account for the
persistence of inequality in health despite temporal changes in the risk factors involved.
Link and Phelan (1995) propose four conditions for determining whether SES is a basic
cause of health inequality. The ﬁrst two conditions are: (1) SES inﬂuences multiple
disease outcomes, (2) through multiple risk factors. These propositions suggest that the
persistence of the association between SES and health cannot be explained only by analys-
ing contingent associations produced by particular risks and speciﬁc outcomes. Instead,
these two propositions point to the relevant role played by changes in risks and health con-
ditions and to the preservation of the association between SES and health beyond a par-
ticular risk proﬁle at a given time. The third condition is as follows: (3) SES involves access
to ‘ﬂexible resources’ that can be used to avoid or minimise the consequences of a disease
when it occurs. The concept of ﬂexible resources thus plays a central role in the theory, as
it highlights the diﬀerential access to money, knowledge, power, prestige and beneﬁcial
social relationships that inﬂuence the ability of individuals to avoid risk and adopt protec-
tive strategies in relation to diseases and treatments, as well as to possess knowledge con-
cerning the risks associated with and changes in these diseases and treatments. The ﬁnal
condition holds that (4) the association between SES and health is reproduced over time
through the replacement of intervening mechanisms. Changes in the incidence/prevalence
of diseases, the risk of these diseases, knowledge about these risks and the eﬀectiveness of
treatments do indeed make it possible to apply the concept of the fundamental social
causes of disease. This is because such changes give rise to new mechanisms, which
replace or overlap the previous ones (Link & Phelan, 1995). Based on the four conditions
posed by Link and Phelan (1995), our ﬁrst assumption (H1) is that SES inequalities in pre-
ventive health practices manifest themselves in the uptake of multiple preventive measures
– FOB tests, PSA tests, Pap smears, mammograms, cholesterol readings and blood-
pressure checks – as societies gain control over diseases via new preventive knowledge.
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Clouston and colleagues (2016) add a temporal context to FCT with their idea of the
‘social history of disease’. Proceeding from the development of preventive knowledge
and innovations, they consider health inequality in cause-speciﬁc mortality at a given
time and place as a four-stage process. The ﬁrst stage – natural mortality – is characterised
by a lack of knowledge about prevention or eﬀective treatment, and thus few, if any diﬀer-
ences in mortality between people of diﬀerent SES. During this stage, any SES diﬀerences
that might exist do not always disadvantage those at the lower end. The second stage,
which is characterised by the production of health inequalities, starts as a society develops
new capacities for reducing the risk of mortality from a particular disease. In this stage, the
beneﬁts of new preventive capacities are unequally distributed across SES levels, such that
health inequalities in mortality emerge for the speciﬁc cause in question. The third stage,
in which health inequalities are reduced, begins as health-beneﬁcial preventive inno-
vations are extended. In this stage, the authors predict stabilisation in health inequalities,
which can also begin to decrease in response to the more even distribution of the new life-
saving knowledge throughout the population. The ﬁnal phase is characterised by reduced
mortality and disease elimination, with inequalities in mortality for the speciﬁc cause
being greatly reduced and possibly even disappearing. According to the principles of
FCT, however, the idea of ‘social history of disease’ suggests the reproduction of health
inequalities over time. This is because new knowledge and possibilities for preventing
cause-speciﬁc mortality will continue to emerge, such that new health inequalities also
continue to arise and proceed through the four stages.
The observations presented above draw a substantial theoretical link to the DOI model
proposed by Rogers (1983). One relevant empirical matter in this regard concerns how
propositions of FCT operate across the diﬀusion of preventive practices. Such an explora-
tion could elaborate the process described by Clouston and colleagues (2016) in greater
depth.
Intersections with the diﬀusion of innovations theory
DOI theory proposes a model in which new preventive technologies or health interven-
tions follow an S-shaped adoption curve, which summarises the process by which these
innovations spread over time within a given social system through personal contacts
and social networks (Rogers, 2003). In the beginning, only a few people will adopt the
innovation, followed by increased and accelerated adoption amongst the majority of the
population as more and more people become acquainted with it. According to Rogers
(2002), this rate of adoption suggests ﬁve distinct ‘adopter categories’: innovators, early
adopters, early majority, late majority and laggards.
Given that people adopt innovations when they come in contact with other individuals
like themselves who have already adopted them (Rogers, 1983), the spread of innovations
through a population can be perceived in terms of social contagion (Centola, 2011;
Centola & Macy, 2007). For the diﬀusion of ‘complex’ social contagions, which are
costly, diﬃcult or unfamiliar and typically include preventive practices, people require
social reinforcement from multiple adopters in order to be convinced to adopt the inno-
vations themselves (Centola, 2015; Centola & Macy, 2007; Guilbeault, Becker, & Centola,
2018). Social networks and their social composition (gender, education, occupation, eth-
nicity, neighbourhood and geographical region) thus play an important role in
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determining the way in which preventive practices and other complex contagions are
likely to diﬀuse within a heterogeneous population (Guilbeault et al., 2018; Rogers,
2003). Empirical evidence has demonstrated that preventive measures diﬀuse more
easily and rapidly within social systems characterised by a high degree of homophily
(Centola, 2011) and interconnectedness (Rogers, 1983). Accordingly, earlier adopters
share similar traits that diﬀerentiate them from later adopters, and they are more
highly interconnected in the social system (Rogers, 1983).
Innovators and early adopters generally diﬀer from later adopters in terms of their per-
sonal characteristics, and they tend to have had more years of education and higher social
status (Rogers, 1983). As a consequence of these disparities amongst adopters, systematic
social inequalities can emerge if diﬀerent social strata vary in the pace at which they adopt
a given innovation (Elstad, 2013). This situation entails several intersections with FCT,
particularly regarding the basic assumption that access to and use of ﬂexible resources
can generate systematic diﬀerences in the early adoption of preventive practices and beha-
viours. Accordingly, people with higher SES are likely to take advantage of new health-
enhancing opportunities as they emerge, or when speciﬁc healthy practices begin to be
socially perceived as innovative. This highlights that innovations spread from high-
status to low-status positions in a social-hierarchical process (Lindbladh, Lyttkens,
Hanson, & Östergren, 1997). As a consequence, SES inequalities may emerge at the begin-
ning of the diﬀusion process, reach a peak in the middle stages and gradually decline
during the ﬁnal stage as shown in Figure 1 (Elstad, 2013).
In this paper, we assume that DOI theory complements the propositions of FCT and
that, together, they provide a theoretical framework for understanding the dynamic inter-
action process between the characteristics of innovations, potential adopters and the
inﬂuence of contexts in which multiple sources of preventive knowledge, technologies
and behaviours are diﬀused simultaneously. Following the fourth proposition of FCT,
Figure 1. Proposed pattern of health inequality along the diﬀusion of innovation (DOI) model. Adapted
from: Rogers (2003).
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and in line with the arguments suggested by Elstad (2013) and by Clouston and colleagues
(2016), our second assumption (H2a) is that the extent of SES inequalities in preventive
health practices will vary according to the diﬀusion stage of each speciﬁc preventive
measure. More speciﬁcally, we expect (H2b) that an early diﬀusion stage will be
accompanied by the absence or emergence of SES inequalities, while intermediate stages




We use data from the Onco-barometer survey, which was designed and implemented by the
Centro de Investigaciones Sociológicas (CIS) and the Spanish Association Against Cancer
(AECC) between November and December 2010. The Onco-barometer consisted of 7938
face-to-face interviews with members of the non-institutionalised Spanish adult population
(aged 18 years or older) – excluding the autonomous cities of Ceuta and Melilla – concern-
ing perceptions, general attitudes and knowledge about cancer, risk factors, treatments and
healthcare assessment. Our analyses are restricted to adults between 50 and 69 years age,
thus ensuring that we address only an age group for which all of the screenings and readings
assessed are recommended. In addition, some health conditions increase the possibility of
being involved in preventive care, sometimes even as part of the treatment. For this
reason, people who had been diagnosed with cancer at some point in their lives (N = 206;
6.1%) and people with cardiovascular disease (N = 429; 12.8%) were omitted in analyses
concerning cancer screening; blood-pressure checks and cholesterol readings, respectively.
This resulted in the following weighed samples, following the exclusion of accumulated
missing cases for each preventive practice: 1904 respondents for FOB tests, 889 men for
PSA tests, 943 women for Pap smears, 965 women for mammograms and 1642 persons
for both cholesterol readings and blood-pressure checks.
Variables
The dependent variables are six preventive healthcare measures at diﬀerent stages of the
diﬀusion cycle: (1) FOB tests, used for colorectal cancer screening; (2) PSA tests for the
detection of prostate cancer in men; (3) Pap smears and (4) mammograms for cervical
and breast cancer screening (respectively) in women; and (5) cholesterol readings and
(6) blood-pressure checks, which constitute two key practices for the prevention of cardi-
ovascular morbidity and mortality. Respondents were asked the following question: ‘Can
you tell me whether you have participated in any of the following tests and checks in the
past two years on your own initiative, on the explicit orders of a doctor or within an annual
periodic review?’ To simplify the analysis, we consider only two categories (1 = yes; 0 = no)
for each dependent variable.
In Spain, FOB tests are performed at two-year intervals within the population between
the ages of 50 and 69 years (Basu et al., 2018). Except for some regions that were in the
pilot phase when the data from this research were compiled, most regions have provided
FOB tests through an organised population-based colorectal cancer screening program
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during the 2000s. In contrast, PSA tests are not organised within any population-based
preventive screening programme. Most major urology societies do not recommend such
programmes, given the mixed evidence concerning the eﬀectiveness of PSA tests in an
asymptomatic population (Calonge et al., 2008). Such tests are nevertheless frequently
used to explore the risk of prostate cancer. Pap smears to detect cervical cancer are rec-
ommended at intervals of 3–5 years for Spanish women between the ages of 25 and 69
years (Ministerio de Sanidad, Servicios Sociales e Igualdad, 2013). Since the mid-1980s,
Pap smears have been implemented in most Spanish regions, albeit not in an organised
screening programme, but in the form of opportunistic screening. Their use thus
depends on the spontaneous initiative of individual women or their physicians. In con-
trast, the early detection of breast cancer through mammograms is organised in a popu-
lation-based screening programme that systematically identiﬁes all Spanish women
between the ages of 50 and 69 years (in some regions, 45–69 years) and invites them to
have a mammogram every two years (Basu et al., 2018). Cholesterol readings to screen
dyslipidaemia are recommended for women 45 years of age and older and for men begin-
ning at the age of 40 years (San Vicente Blanco et al., 2008). Blood-pressure checks to
detect hypertension (and other medical conditions) are recommended every two years
for people 40 years of age or older (Pérez, 2002).
The main independent variable in this study is socioeconomic status (SES). In order to
avoid problems of multicollinearity due to the inclusion of both educational level and
social class in the statistical models, we decided to use a composite indicator of SES. To
this end, we performed a principal component analysis (PCA) including educational
level and social class (See supplementary material for the operationalisation of both vari-
ables and PCA). This analysis yielded one extracted factor with a satisfying internal con-
sistency (Cronbach’s alpha = 0.72), which explains approximately 78% of the variance.
The integrated metric indicator ranges between −1.53 and 2.14, with higher scores indi-
cating higher SES.
In our analysis, we account for age (ranging from 50 to 69 years), gender (female or
male) when applicable, work status (employed, unemployed or non-employed), marital
status (married, separated or divorced, single or widower), self-perception of the risk of
developing cancer in one’s lifetime (high/very high or low/very low) and the presence
of other chronic diseases other than cancer (no or yes). Finally, we consider whether
respondents had any relatives or friends who had died of cancer or who had been diag-
nosed with cancer (no or yes), as contact with the disease through family or close
friends can also play a relevant role in the regular use of checks and screenings
(Lerman, Rimer, Trock, Balshem, & Engstrom, 1990; Rees, Martin, & Macrae, 2008).
Statistical analyses
The statistical analyses were performed in three steps. First, for each preventive measure,
we calculated both the rate of adoption and the rate of spontaneous knowledge amongst
the Spanish population between the ages of 50 and 69 years. The rate of spontaneous
knowledge was retrieved from the respondents’ answers to the question concerning the
cancer-detection techniques of which they were aware. Based on the rates of adoption
and knowledge, we linked each preventive measure to a speciﬁc diﬀusion stage, following
the logic that low rates imply an early diﬀusion stage, and vice versa. Second, we estimated
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the adoption rate for each preventive practice by age, gender (when applicable), work
status, marital status, self-perception of the risk of developing cancer, and having relatives
or friends who had either died from or been diagnosed with cancer. Third, to examine
whether and how SES is associated with the adoption of preventive healthcare, we per-
formed logistic regressions for each preventive practice. Regression coeﬃcients were
adjusted for age, gender (when applicable), work status, marital status, self-perception
of the risk of developing cancer, presence of other chronic diseases and having relatives
or friends who had either died of or been diagnosed with cancer. Odds ratios (OR) and
the accompanying 95% conﬁdence intervals (CI) are presented to facilitate interpretation.
Finally, to explore how the eﬀects of SES emerge and evolve along the diﬀusion cycle, we
displayed the OR on a ﬁgure. Logistic models were computed using SPSS software version
22. Population weights according regional survey design were applied to arrive at valid
estimations for the country as a whole.
Results
The rate of spontaneous knowledge and the rate of adoption for each preventive practice
are displayed in Table 1, along with the diﬀusion stage linked to each preventive measure
based on these rates.
We determined that FOB testing was in an early stage of diﬀusion, as it had the lowest
rates of both spontaneous knowledge (3%; 95% CI: 2.4–3.9) and adoption (9%; 95% CI: 8–
10.4). This is not surprising, given that the ﬁrst relevant screening programmes for color-
ectal cancer were not implemented until 2000 in Catalonia, followed by the Valencian
Community in 2005 and Murcia in 2006. Other regions either started implementing
FOB tests after 2006 or were in a pilot phase. Based on our results, we classiﬁed PSA
tests as being in the early majority stage of diﬀusion, as only 12% of the men spontaneously
indicated being aware of PSA tests as a screening method for detect cancer, and approxi-
mately 35% had used this type of screening in the past two years. Pap smears were
classiﬁed as being at the end of the early majority stage or the beginning of the late
majority stage. Of all female respondents, 23% spontaneously identiﬁed the Pap smear
as a test for the early detection of cancer, and the rate of adoption in the past two years
was 64%. With spontaneous knowledge and adoption rates of 53% and 81%, respectively,
we classiﬁed mammograms in the late majority stage. Cholesterol readings and periodic
blood-pressure checks were classiﬁed as being in a late stage of diﬀusion, as approximately
83% of all respondents between the ages of 50 and 69 years reported having had choles-
terol readings taken, and 84% reported having had their blood-pressure checked within
the two years prior to the survey.
The unadjusted adoption rates for each preventive measure according to SES are dis-
played in Table 2. Although the results reﬂect some SES diﬀerences in the adoption of
FOB tests (SES I = 9.7% vs. SES IV = 5.9%), these diﬀerences were not statistically signiﬁ-
cant (p = 0.205). Prominent signiﬁcant (p < 0.001) diﬀerences between the highest and
lowest SES groups emerged for PSA tests (SES I = 43.7% vs. SES IV = 30.9%). The socio-
economic gradient was also evident in the case of Pap smears (SES I = 77.2% vs. SES IV =
59%; p = 0.001) and mammograms, albeit less pronounced (SES I = 87.7% vs. SES IV =
79.6%; p = 0.021). Very slight diﬀerences according to SES were observed for cholesterol
readings and blood-pressure checks, but these were not signiﬁcant (p = 0.182; p = 0.351).
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population aged 50–69 years (%)
Rate of adoption amongst
population aged 50–69 years in the
past two years
Stage of DiﬀusionPrevalence 95% CI Prevalence 95% CI Prevalence 95% CI
FOB tests 2.50 2.20 2.80 3.18 2.4 3.9 9.17 8.0 10.40 early stage
PSA tests 5.27 4.80 5.80 12.07a 9.9 14.2 35.52a 32.34 38.70 early majority
Pap Smears 13.00 12.30 13.70 23.29b 20.7 25.8 64.23b 61.30 67.10 early majority/late majority
Mammograms 36.03 35.00 37.10 53.43b 50.4 56.4 81.50b 79.20 82.80 late majority
Cholesterol readings No information – – No information – – 83.05 81.50 84.60 late majority/laggards
Blood-pressure checks No information – – No information – – 84.13 82.60 85.70 late majority/laggards
aOnly men; bOnly women.
Table 2. Unadjusted rate of adoption, by SES.
FOB tests PSA tests Pap Smears Mammograms Cholesterol readings Blood pressure checks
% 95% CI % 95% CI % 95% CI % 95% CI % 95% CI % 95% CI
SES
SES I (≥1) 9.7 6.75 12.58 43.7 36.7 50.9 77.2 71.4 83.1 87.7 83.2 92.2 79.6 75.4 83.8 82.1 78.2 86.1
SES II (1–0) 10.3 7.3 13.4 39.6 32.7 46.6 71.2 65.2 78.6 88.7 84.0 93.3 84.6 80.7 88.5 85.6 81.8 89.4
SES III (0–−1) 8.4 6.5 10.2 24.4 20.4 28.5 62.8 61.2 70.5 81.5 77.8 85.2 82.5 79.8 85.3 82.3 79.6 85.1
SES IV (≤−1) 5.9 3.2 8.7 30.9 20.9 41.0 59.0 52.1 65.9 79.6 73.9 85.2 78.5 73.2 83.8 79.9 74.8 85.1
Chi2 test (Sig.) 4.58 (0.205) 28.49 (0.000) 17.13 (0.001) 9.69 (0.021) 4.86 (0.182) 3.27 (0.351)













In Table 3, we present the results of our exploration of whether SES inequalities become
manifest in the uptake of multiple preventive measures (in line with the propositions of
FCT). In this regard, the results indicate that not all of the six preventive practices were
subject to signiﬁcant SES inequalities. More speciﬁcally, we could not conﬁrm SES
inequalities in the use of FOB tests (OR = 1.14; 95% CI: 0.96–1.35), blood-pressure
checks (OR = 1.07; 95% CI: 0.96–1.20) and cholesterol readings (OR = 1.06; 95% CI:
0.95–1.18). In contrast, we observed that higher SES increases the likelihood of using
PSA tests (OR = 1.50; 95% CI: 1.28–1.75), Pap smears (OR = 1.33; 95% CI: 1.14–1.55)
and mammograms (OR = 1.31; 95% CI: 1.08–1.59).
The results presented in Table 3 are accompanied by Figure 2, in which we present the
OR for SES and their accompanying 95% CI for each preventive practice. As indicated in
this ﬁgure, the extent of SES inequalities in the adoption of preventive practices varies sig-
niﬁcantly according to the diﬀusion stage of each preventive measure – the higher the OR,
the greater the inﬂuence of SES and, therefore, the greater the inequality in the adoption of
the preventive practice. In line with our expectations, the inﬂuence of SES appeared to
emerge for preventive practices in an early stage of diﬀusion (in our case, FOB tests),
and it was prominent for measures that were classiﬁed as being in the early majority
stage (PSA tests) and the intermediate (between the early and late majority) diﬀusion
stage (Pap smears). As reﬂected by the results for mammograms in Spain, SES inequalities
persisted in the late majority stage, despite the extensive rate of mammography adoption.
Finally, in the last stage of diﬀusion (late majority-laggards), when the dissemination
process is close to saturation (as was assumed for cholesterol readings and blood-pressure
checks in Spain), we observed no signiﬁcant SES diﬀerences in adoption.
Discussion and conclusion
The primary aim of the current study was to elaborate on the substantial interconnections
between FCT and DOI theory, given that a framework integrating the two theories could
provide a more comprehensive understanding of the reproduction and persistence of
health inequalities. In the study, we evaluated several of these interconnections empiri-
cally, by focussing on the inﬂuence of SES on the use of six diﬀerent preventive practices
in Spain, which neatly span the various stages of diﬀusion of knowledge and adoption.
According to the propositions of FCT, SES inﬂuences multiple disease outcomes
through multiple risk factors. Our ﬁrst assumption was therefore that the six preventive
measures (FOB tests, PSA tests, Pap smears, mammograms, cholesterol readings and
blood-pressure checks) would be subject to SES inequalities (H1). This was the case for
the use of cancer screening tests (PSA tests, Pap smears and mammograms), but not
for preventive practices at early diﬀusion stage, like FOB tests, and for cardiovascular dis-
eases (blood-pressure checks and cholesterol readings). This result implies that associ-
ations between SES and preventive practices do not always exist at a speciﬁc place and
time. Drawing on DOI theory, this ﬁnding could be explained in part by variations in
the association between SES and preventive practices according to diﬀusion stage
(Boscoe & Zhang, 2017; Clouston et al., 2017; Wang et al., 2012). This explanation is in
line with the second hypothesis, which states that the extent of SES inequalities in preven-
tive practices varies according to the diﬀusion stage of each preventive measure (H2a).
Moreover, in line with Elstad (2013) and Clouston and colleagues (2016), we observed
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Table 3. Inﬂuence of SES on the regular use of preventive practices at diﬀerent diﬀusion stages.
FOB tests PSA tests Pap Smears Mammograms Cholesterol readings
Blood-pressure
checks
OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age 1.01 0.98 1.05 1.07 1.03 1.11 *** 0.95 0.92 0.98 *** 0.99 0.95 1.02 1.03 1.00 1.06 * 1.04 1.01 1.07 **
Women (ref. Men) 0.78 0.55 1.09 – – – – – – – – – 0.73 0.55 0.96 * 0.93 0.71 1.23
Work status (ref. Employed)
Unemployed 1.75 1.03 2.99 * 1.40 0.85 2.30 1.69 0.94 3.04 2.00 0.94 4.24 1.02 0.67 1.56 0.73 0.48 1.11
Non-employed 1.28 0.83 1.98 1.15 0.76 1.74 1.18 0.81 1.72 1.41 0.89 2.21 1.26 0.90 1.76 0.89 0.63 1.25
Marital status (ref. Married)
Separated or divorced 1.01 0.54 1.89 0.87 0.48 1.58 1.02 0.55 1.86 1.24 0.56 2.74 0.86 0.52 1.42 0.80 0.49 1.30
Single 0.59 0.29 1.20 0.56 0.32 0.99 * 0.85 0.48 1.50 0.58 0.31 1.10 0.73 0.47 1.14 0.90 0.56 1.43
Widower 0.72 0.36 1.46 0.41 0.16 1.10 0.94 0.61 1.45 0.84 0.50 1.44 0.74 0.45 1.20 0.70 0.43 1.15
Self-perception of the risk of developing
cancer in one’s lifetime (ref. Low or very
low)
1.42 1.02 1.97 * 1.23 0.90 1.68 0.73 0.55 0.98 * 0.92 0.64 1.33 1.27 0.97 1.68 0.87 0.66 1.14
Relative or friend died from cancer (ref. No) 1.88 1.15 3.06 * 1.65 1.13 2.40 ** 1.18 0.82 1.72 1.46 0.94 2.24 1.32 0.97 1.78 1.48 1.09 2.01 *
Relative or friend currently has cancer (ref. No) 1.47 1.05 2.06 * 1.42 1.04 1.93 * 1.16 0.88 1.55 1.21 0.85 1.73 1.31 1.00 1.72 * 1.29 0.98 1.69
Other chronic diseases or health problems
(ref. No)
1.04 0.75 1.45 1.34 0.99 1.82 * 1.09 0.82 1.45 1.20 0.84 1.71 1.59 1.22 2.08 *** 1.76 1.34 2.31 ***
SES 1.14 0.96 1.35 1.50 1.28 1.75 *** 1.33 1.14 1.55 *** 1.31 1.08 1.59 ** 1.02 0.89 1.17 1.01 0.88 1.17
R2 Nagelkerke 3.9% 13.20% 6.00% 3.40% 4.60% 4.60%
N 1904 889 943 965 1642 1642













that an early diﬀusion stage is accompanied by the absence or emergence of SES inequal-
ities, with an intermediate stage accompanied by a high level of inequalities and an
advanced stage with the reduction or absence of inequalities. The extent of SES inequalities
in Spain for each preventive measure studied was in accordance with its diﬀusion stage:
SES inequalities seemed to be emerging for FOB tests (early stage of diﬀusion), the greatest
for PSA tests (early majority), smaller but existent for Pap smears and mammograms
(intermediate early-late majority and late majority stage) and absent for cholesterol read-
ings and blood-pressure checks (late diﬀusion stage). These ﬁndings suggest that the social
institutionalisation of preventive practices can strongly reduce social disparities.
Our results have several theoretical and empirical implications for the persistence of
social inequalities in health. First, we suggest that a theoretical framework integrating
FCT and DOI theory could help to develop a more extensive and complete explanation
for the ‘health inequality paradox’ in more generous and extensive European welfare
states (Mackenbach, 2012, 2017). Despite improvements in their ability to control diseases
by extending preventive policies and eﬀective reforms aimed at the pre-distribution of
health and focusing on the redistribution of resources, rather than on ‘capabilities’
(Abel & Frohlich, 2012), modern welfare states have not succeeded in reducing health
inequality since the 1990s (Pega, Blakely, Carter, & Sjöberg, 2012). Moreover, most
public health programmes have focused on ‘downstream’ interventions (e.g. eﬀecting life-
style changes) to reduce health inequalities. As suggested by FCT (Link & Phelan, 1995),
however, it is crucial to address the underlying causes of the causes or ‘upstream’ social
conditions (Marmot, 2005; Syme, 2002; Watt, 2007). Although DOI theory has been con-
sidered as a possible explanation for this apparent ‘health inequality paradox’, the argu-
ment has been advanced that, on its own, the theory may explain only the ‘temporary
widening of health inequalities when major improvements in population health occur
that are mediated by behaviour change’ (Mackenbach, 2012, p. 765). According to our
interpretation, however, the interconnections between FCT and DOI theory overrule
this argument. By introducing the idea of fundamental causality, the cycle described by
Figure 2. Trend of SES inﬂuence at diﬀerent diﬀusion stages. The dotted line represents the 95%
conﬁdence interval of the OR.
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DOI theory could be repeated constantly over time, in line with the distribution of ﬂexible
resources linked to SES. This may help to explain the widening and diminishing of health
inequalities because of the accumulated eﬀect of disseminating multiple preventive prac-
tices, innovations and new health knowledge over time. The combination of FCT and DOI
theory thus clearly reveals that existing explanations for the persistence of social inequal-
ities in health tend to be too static in their focus on a ‘paradox’, as they tend to ignore the
shifting relationship between inequality and the use of preventive innovations along the S-
shaped curve predicted by DOI theory. Future research should therefore draw on the
interconnections of FCT and DOI theory to adopt a more dynamic approach.
Second, variations between social groups and cohorts in the extent of inequalities in the
use of preventive care reveal an explanatory shortcoming of FCT. More speciﬁcally, as
observed by Masters, Link, and Phelan (2015, pp. 26–27), the explanatory core of FCT,
which rests on the relevance of purposeful use of individual ﬂexible resources, lacks any
theoretical elaboration on how the eﬀective beneﬁts of these resources vary across
diﬀering social contexts. However, the conjunction with DOI theory adds a contextual
and temporal dimension to FCT. This integration may help to improve the conceptualis-
ation of the dynamic causal relationships between SES and health outcomes, in addition to
enhancing the exploration of how this dynamic association is shaped by contemporary
social changes/processes in the diﬀusion of relevant health knowledge. Further, given
that the reproduction of health inequalities does not depend exclusively on resources at
the individual level, the next theoretical step might be to identify and elaborate on the
elements that shape the ‘preventive diﬀusion context’ at diﬀerent levels (e.g. neighbour-
hoods, regions, countries). Particularly when studying complex contagions such as pre-
ventive practices, which require social reinforcement to diﬀuse, attention should be
paid to network structures (i.e. who is connected to whom) (Centola, 2010; Centola &
Macy, 2007; Rogers, 1983). Findings from an experimental study with artiﬁcially struc-
tured online communities have demonstrated that individual adoption of health inno-
vations is much more likely to diﬀuse in clustered neighbourhood networks, due to
social reinforcement of multiple neighbours (Centola, 2010; Guilbeault et al., 2018).
This mirrors the importance of neighbourhoods’ social cohesion and social capital for
the likelihood of adoption (Kawashi & Berkman, 2014). It is, therefore, likely that connec-
tions exist between the diﬀerent adopter categories and their neighbourhoods’ cohesive-
ness. Exploring how preventive diﬀusion contexts and network structures contribute to
equality in the adoption of multiple preventive innovations is, thus, a promising research
area for advancing understanding of variations in health inequality across places and social
strata.
Third, the diﬀusion model has been criticised for its inability to reveal any explanatory
mechanisms beyond the imitation of behaviour (Mackenbach, 2012). The underlying idea
is that an innovation is ﬁrst adopted by high-status individuals (social ‘leaders’) and then
by low-status individuals (social ‘followers’), who imitate the behaviour of the ‘leaders’
(Lindbladh et al., 1997). This argument suggests that inequalities may be ‘largely tempor-
arily unavoidable as a consequence of modernisation’ (Mackenbach, 2017, p. 16).
Although imitation mechanisms could be operating in the process, the conjunction of
FCT and DOI could open the door for investigating alternative mediating paths by explor-
ing the role played by various ‘meta-mechanisms’ along the diﬀusion cycle of preventive
innovations. In addition to the relevance of personal agency, Freese and Lutfey (2011)
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stipulate three meta-mechanisms that contribute to the reproduction of health inequal-
ities: (1) spill-over eﬀects between individuals through their social networks; (2) socially
structured health preferences as part of a habitus, related to social positions (Bourdieu,
2002); and (3) institutional agency, in which institutions (e.g. the healthcare system and
schools) contribute to the preservation of health inequalities to the extent that they
treat individuals diﬀerently according to their social class, gender, race or age. We
invite scholars to explore the relative importance of these meta-mechanisms along the
diﬀusion cycle of relevant preventive innovations, thereby contributing to further theor-
etical development within the ﬁeld.
Several limitations of the present study should be noted. First, we ignored diﬀerences in
the ease of using various preventive practices, as well as in the ways in which they are pro-
vided and in how these diﬀerences aﬀect their diﬀusion through a population.More speciﬁ-
cally, it has been shown that preventive practices provided by specialists (Lorant, Boland,
Humblet, & Deliège, 2002), which require considerable behavioural eﬀort (Goldman &
Lakdawalla, 2005) and which depend upon the spontaneous initiative of individuals or
physicians (Palència et al., 2010; Walsh, Silles, & O’Neill, 2011; Willems & Bracke,
2018), enhance inequality more than is the case for preventive practices provided by
general practitioners, which involve simple technologies and are organised in popu-
lation-based programmes (e.g. organised cancer screening programmes). We also paid
no attention to the potential accumulation of disadvantage across the lifespan and the
timely initiation of preventive care (Missinne, 2015). Given that some preventive care
takes place later in life, we could expect this care to be more unequal. We addressed this
issue by limiting the sample to the same age categories. Future research could apply an inte-
grated theoretical framework of FCT and DOI theory to a more complete exploration of
these lifespan eﬀects, in addition to considering potential cohort eﬀects that might occur
in response to social changes relating to the diﬀusion of preventive social practices.
Second, our data did not allow us to consider the temporal diﬀusion of each preventive
practice along the path suggested by the S-shaped curve. At a minimum, this would
require a repeated cross-sectional design extended over a long period. Finally, this study
focuses on the diﬀusion contexts of multiple preventive practices in one speciﬁc country.
Future research should study the diﬀusion cycle of multiple preventive measures in
cross-national comparative perspective, integrating questions regarding how speciﬁc
characteristics of macro-diﬀusion contexts and institutional agency can inﬂuence the mag-
nitude of health inequalities across countries or other relevant geographic areas.
In conclusion, our ﬁndings highlight the importance of the diﬀusion of innovative
preventive technologies and its impact on the generation and reduction of inequalities
in preventive care practices as greater control over diseases is developed (Phelan &
Link, 2005). Taken together, FCT and DOI theory can provide an integrated framework
with which to study health inequalities in the adoption of preventive practices from a
temporal and comparative perspective. This integration has the potential to bring
‘social change’ back into the study of health inequalities, which is essential in order to
understand transitions in health practices (Dixon & Banwell, 2009). The ﬁndings that
we have reported suggest that, while social inequalities in speciﬁc preventive care prac-
tices tend to arise and disappear along the continuing process of technological inno-
vations in cancer screening, they tend to be reproduced overall. This paradox requires
our full attention.
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